Orphenadrine Citrate NDC 63187-632

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-632Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0632Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-632-30	63187063230	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-632-30)Marketed from Jan 1, 2016
63187-632-60	63187063260	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-632-60)Marketed from Jan 1, 2016
63187-632-90	63187063290	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-632-90)Marketed from Jan 1, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Orphenadrine Citrate
Generic name (nonproprietary): orphenadrine citrate
Active ingredients: Orphenadrine citrate — 100 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040327
Marketing start: Feb 15, 2000
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 63187-632_77186922-128f-4ed4-8caa-b45fce773345SPL ID 77186922-128f-4ed4-8caa-b45fce773345SPL set ID 37e6a157-5d0d-4887-9a26-ed5521fb08e6RxCUI 994521UNII X0A40N8I4S
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187063230 followed by a unit qualifier and the quantity

Package 63187-0632-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 1, 2019.

Indications (excerpt from the label)

INDICATIONS Orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions. The mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. Orphenadrine citrate does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040327

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040327
Product	Strength	Form · route	Labeler	Product NDC
Orphenadrine Citrate	Orphenadrine citrate 100 mg/1	Tablet, Extended releaseOral	RedPharm Drug	67296-1077
Orphenadrine Citrate	Orphenadrine citrate 100 mg/1	Tablet, Extended releaseOral	Sandoz Inc	0185-0022